Endava plc (DAVA)
Valuation Overview•Is Endava plc Overvalued or Undervalued?
Trading at a relative discount to industry peers, suggesting a specific risk premium is applied.
Fragile underlying quality score of 40/100; weak margins or elevated debt leverage warrant caution.
Analysts remain bullish, forecasting further upside expansion with consensus targets suggesting solid gains.
Verdict: Average quality business weighed down by significant profitability concerns.
Wall Street is highly bullish, projecting significant upside alongside robust expected earnings growth. This outlook is strongly supported by highly attractive capital returns, driven predominantly by aggressive share repurchases.
Returns capital exclusively via buybacks — no active dividend
DAVA struggles with subpar profitability and pressured margins. However, the balance sheet carries elevated leverage, requiring careful monitoring of debt servicing capabilities.
The company demonstrates solid revenue growth (5.7% 3Y CAGR) however, earnings have severely contracted over the same period. However, profitability remains a major concern with severely compressed operating margins (-0.6%).
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $182.4M | +4.3% | +5.7% | +17.1% | +24.8% | |
| EBITDA | $3.6M | — | -18.2% | — | — | |
| Net Income | -$403.0M | +23.9% | -36.6% | — | +4.6% | |
| EPS (Diluted) | $-7.71 | +24.1% | -36.9% | +0.0% | +2.2% | |
| Free Cash Flow | -$5.6M | -1.7% | -23.4% | +9.6% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 20.3% | 28.1% | 30.4% | 31.5% |
| Operating Margin | -0.6% | 7.0% | 10.0% | 11.0% |
| Net Margin | -57.2% | 5.6% | 7.9% | 8.7% |
| FCF Margin | 2.4% | 8.9% | 12.3% | 10.5% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.27 | $0.07 | -74.1% | ||
| Q1'26 | $0.21 | $0.21 | +0.0% | ||
| Q4'25 | $0.24 | $0.20 | -18.3% | ||
| Q3'25 | $0.32 | $0.32 | +0.0% | ||
| Q2'25 | $0.40 | $0.24 | -40.3% | ||
| Q1'25 | $0.33 | $0.38 | +16.6% | ||
| Q4'24 | $0.29 | $0.33 | +15.3% | ||
| Q3'24 | $0.29 | $0.28 | -2.1% |
Total return is -81.7% (1Y), lagging the benchmark by -102.5%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -55.7% | -63.0% | — |
| 1Y | -81.7% | -102.5% | — |
| 3YCAGR | -61.7% | -81.3% | — |
| 5YCAGR | -52.9% | -64.6% | — |
| 10YCAGR | -20.0% | -33.9% | — |
The S&P 500 is at 30.6x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Endava plc (DAVA) valuation, health, and returns.
Based on peer relative multiples, Endava plc appears Cheap versus peers compared to industry peers.
Endava plc has multiple valuation anchors: Peer Relative Fair Value: $4.57 | Wall Street Analyst Target: $5.00 (implying +76.1% upside). A convergence of these signals offers higher conviction.
Endava plc displays fair financial health with a composite quality score of 40/100, supported by a Altman Z-Score of 1.9 (grey zone), Piotroski F-Score of 7/9, Return on Invested Capital (ROIC) of 3.1%.
Endava plc returns capital via buybacks instead of dividends, carrying a 56.2% buyback yield and reducing outstanding shares by +0.1% in the last 12 months.
Endava plc's current growth trajectory is Stable. The company achieved +4.3% 1Y revenue growth and +24.1% 1Y EPS growth, compared to its 3Y revenue CAGR of +5.7%.
Wall Street consensus is Hold based on 16 analysts, beating EPS expectations in 42% of recent quarters with a -5-quarter streak. The consensus price target represents a +76.1% change from current levels.
Investment risks for Endava plc include: -83.4% 1-year max drawdown. Volatility risk is characterized by a beta of 1.27x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.